Indian Drug Price Regulator Opposes Plans To Clip Its Wings

An Aug. 30 stakeholder meeting on India’s contentious draft pharmaceutical policy was an unusual mix of radical suggestions, simmering tensions and a changed agenda. With voices of opposition growing, including from within the government, it’s unlikely to be smooth sailing for the draft, at least in its current form.